Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice

BACKGROUND: Evidence of eribulin therapy for metastatic breast cancer (MBC) in clinical practice is not well documented. METHODS: We retrospectively analyzed the safety and efficacy of eribulin in 29 MBC patients from 2011 to 2016 at Fukuoka University Hospital. RESULTS: The median patient age, numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Toshihiro, Ueno, Miho, Nakashima, Yuta, Chinen, Shotaro, Sato, Eiichi, Masaki, Michio, Mogi, Ai, Sasaki, Hidenori, Tamura, Kazuo, Takamatsu, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588851/
https://www.ncbi.nlm.nih.gov/pubmed/28741868
http://dx.doi.org/10.1111/1759-7714.12482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588851/
https://www.ncbi.nlm.nih.gov/pubmed/28741868
http://dx.doi.org/10.1111/1759-7714.12482

Ejemplares similares